Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
$29.19
-0.85%today
MKT CAP
$1.5B
-9.5% · 1Y
Earnings History
+24.0%
+7.0%
+17.9%
+12.2%
Q2 '25
Q3 '25
Q4 '25
Q1 '26
Analyst Targets
Current price
$29.19
Low
$50.00
Analyst Mean
$66.80
High
$88.00
10 analystsStrong Buy
Full Financials
Trailing P/E-
Forward P/E-
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ-
5y Revenue CAGR-
5y Earnings CAGR-
Gross Margin0.0%
Operating Margin0.0%
Net Margin0.0%
ROE-
Debt / Equity0.16x
Free Cash Flow-
Insider Ownership2.7%
Institutional Ownership109.5%
Short % of Float11.17%
Days to Cover8.0d
1 Week-1.8%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
| Filer | Role | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| HOERTER STEVEN L | Director | Stock | 11,938 | $0.00 | $0.00M | 2026-05-01 |
| HAWRYLUK P KENT | Chief Executive Officer | Buy | 18,500 | $28.41 | $0.53M | 2026-03-13 |
| HAWRYLUK P KENT | Chief Executive Officer | Conversion | 28,768 | $16.00 | $0.46M | 2026-02-26 |
| AZOULAY SALOMON M.D. | Officer | Stock | 15,000 | $0.00 | $0.00M | 2026-02-02 |
| HAWRYLUK P KENT | Chief Executive Officer | Stock | 35,250 | $0.00 | $0.00M | 2026-02-02 |
Top Holders
| Holder | Type | % Held | Value | Δ Shares | As of |
|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | institution | 13.98% | $0.27B | +0.00% | 2025-12-31 |
| Orbimed Advisors LLC. | institution | 8.27% | $0.16B | -1.69% | 2025-12-31 |
| NEA Management Company, LLC | institution | 7.60% | $0.15B | +0.00% | 2025-12-31 |
| Wellington Management Group, LLP | institution | 7.04% | $0.14B | -30.55% | 2025-12-31 |
| Deep Track Capital, Lp | institution | 6.83% | $0.13B | +3.17% | 2025-12-31 |
| Blackrock Inc. | institution | 6.14% | $0.12B | +49.16% | 2025-12-31 |
| NVP Associates, LLC | institution | 4.49% | $0.09B | +0.00% | 2025-12-31 |
| EcoR1 Capital, LLC | institution | 4.46% | $0.09B | +0.00% | 2025-12-31 |
| Vanguard Group Inc | institution | 3.82% | $0.07B | +8.37% | 2025-12-31 |
| Driehaus Capital Management, LLC | institution | 2.96% | $0.06B | -8.54% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | fund | 2.22% | $0.04B | -6.13% | 2025-12-31 |
| MUTUAL FUND SERIES TRUST-Eventide Healthcare & Life Sciences Fund | fund | 1.87% | $0.04B | +100.00% | 2025-12-31 |
| iShares Trust-iShares Russell 2000 ETF | fund | 1.45% | $0.03B | +0.45% | 2026-03-31 |
| T. Rowe Price Health Sciences Fund, Inc. | fund | 1.29% | $0.03B | -12.70% | 2025-12-31 |
| Fidelity Capital Trust-Fidelity Stock Selector Small Cap Fund | fund | 0.87% | $0.02B | +859.84% | 2026-02-28 |
| BlackRock Funds-BlackRock Health Sciences Opportunities Portfolio | fund | 0.70% | $0.01B | -2.12% | 2026-02-28 |
| Fidelity Hastings Street Trust-Fidelity Fund | fund | 0.67% | $0.01B | +100.00% | 2026-03-31 |
| Fidelity Securities Fund-Fidelity Series Small Cap Opportunities Fund | fund | 0.64% | $0.01B | +799.70% | 2026-02-28 |
| Fidelity Advisor Series VII-Fidelity Advisor Biotechnology Fund | fund | 0.64% | $0.01B | +38.45% | 2026-03-31 |
| Fidelity Securities Fund-Fidelity Small Cap Growth Fund | fund | 0.63% | $0.01B | +100.00% | 2026-02-28 |
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Recent Alerts
No alerts yet for MBX.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.